US-Iran War Enters Fifth Week as Oil Surges and Logistics Networks Face Strain

Now in its fifth week, the US-Iran conflict has become the most severe energy crisis in decades, sending commodity markets into sustained disarray and rattling equity benchmarks across the board. Brent crude hit a session high of $119 per barrel on March 19 before settling around $109, then climbed again past $116 on March 30 after Iran accused the United States of preparing a full-scale ground invasion. Diesel has surged past $5.37 per gallon, causing widespread disruption to freight and logistics networks. Crude stored on stationary tankers for seven or more days jumped 47% week-over-week to 136.13 million barrels as of March 31, according to Vortexa data, a figure that underscores how severely Strait of Hormuz disruptions are rerouting global supply chains. President Trump acknowledged the conflict will last several more weeks and offered no exit timeline.

The market response has been muted but tense. As of April 3, the Dow Jones Industrial Average is down 0.13%, while the S&P 500 and Nasdaq have posted marginal gains of 0.11% and 0.18%, respectively. Equities have so far absorbed the oil shock with relative composure, though the risk of escalation remains the central concern for investors. Strikes attributed to Iran have damaged Amazon's cloud infrastructure in Bahrain, and Iran claims to have hit Oracle data center facilities in Dubai. Major logistics operators including Amazon, UPS, FedEx, and USPS have all announced fuel surcharges in response to rising energy costs. Analysts are watching closely for any signal of de-escalation, as a prolonged conflict near the Strait of Hormuz carries meaningful downstream risk for global trade, inflation, and corporate earnings across nearly every sector.

Tesla Misses Q1 2026 Delivery Estimates as Inventory Builds

Tesla delivered 358,023 vehicles in the first quarter of 2026, falling short of the Wall Street consensus of approximately 365,645 units and a StreetAccount estimate of 370,000. The company produced 408,386 vehicles during the same period, resulting in an inventory build of more than 50,000 units in a single quarter. The breakdown by segment is notable: the Model 3 and Model Y accounted for 394,611 units produced versus 341,893 delivered, a gap of roughly 53,000 vehicles. In contrast, the Other Models category, which includes Cybertruck and legacy S and X variants, saw deliveries of 16,130 outpace production of 13,775, suggesting Tesla drew down existing inventory in that segment. Year-over-year, Q1 2026 deliveries represent a 6.3% increase from the 336,681 vehicles delivered in Q1 2025. Energy storage deployments came in at 8.8 gigawatt-hours for the quarter, a 38% decline from Q4 2025's 14.2 GWh and far below the consensus estimate of 14.4 GWh.

The delivery miss arrives at a difficult moment for Tesla. The company is still navigating the aftermath of a year of declining deliveries driven in part by intensifying competition from Chinese electric vehicle manufacturers. Elon Musk's high-profile political activities have been cited by analysts as an additional source of demand headwinds, creating brand friction in key markets. Barron's noted that Wall Street had projected approximately 366,000 deliveries heading into the print, making this the second consecutive year in which first-quarter results underwhelmed. The widening gap between production and deliveries raises questions about near-term pricing strategy, inventory liquidation costs, and demand elasticity. Investors will be watching the upcoming earnings call closely for management commentary on how Tesla plans to close that production-delivery gap and whether Q2 guidance will reflect a course correction or continued pressure.

Eli Lilly Wins FDA Approval for Foundayo, Entering the Oral Obesity Drug Market

The U.S. Food and Drug Administration approved Eli Lilly's once-daily obesity pill orforglipron, marketed under the brand name Foundayo, on approximately April 1-2, 2026. The approval marks a significant milestone in the treatment of obesity and represents the fifth drug cleared under the FDA Commissioner's National Priority Voucher Program, which was launched in June 2025 and compresses the standard review timeline from 10 to 12 months down to just one to two months. Foundayo is a small-molecule GLP-1 receptor agonist taken orally once per day, a formulation distinct from peptide-based injectable competitors. In the Phase 3 ATTAIN-1 trial, the highest 36 milligram dose produced average weight loss of 27.3 pounds at 72 weeks, translating to roughly 11% body weight reduction in patients with obesity but without diabetes, and approximately 10% in those with obesity and Type 2 diabetes. Pricing is set at $25 per month for insured patients using a Lilly coupon, with out-of-pocket costs ranging from $149 to $349 per month depending on dose. The drug will be available through Lilly's LillyDirect direct-to-consumer platform starting Monday, with pharmacy and telehealth availability to follow shortly thereafter.

The commercial implications are substantial. Lilly CEO David Ricks said the pill is "obesity care designed for the real world," emphasizing the convenience of an oral formulation relative to injectables. CFO Lucas Montarce had targeted a Q2 2026 launch contingent on FDA approval, meaning the company is executing ahead of internal schedule. Lilly originally licensed orforglipron from Japanese pharmaceutical company Chugai in 2018 for $50 million upfront. Rival Novo Nordisk moved quickly to defend its own oral obesity drug, with EVP Jamey Millar stating that "not all GLP-1s are the same" and calling claims of orforglipron's superiority over Wegovy pill "inaccurate and misleading." No head-to-head clinical trial between the two drugs exists; Novo Nordisk's oral semaglutide achieved 14% average weight loss in the OASIS 4 trial at a 25 milligram dose. The obesity drug market is forecast to reach $100 billion annually by 2030, and Foundayo's accessible price point and oral dosing could meaningfully expand the addressable patient population, adding a new competitive pressure to Novo Nordisk's dominant market position.

Amazon Imposes 3.5% Fuel Surcharge on FBA Sellers Amid Rising Energy Costs

Amazon announced on April 2, 2026 that it will impose a 3.5% fuel and logistics-related surcharge on Fulfillment by Amazon fees for sellers operating in the United States and Canada. The surcharge takes effect April 17 for standard FBA services and May 2 for Buy with Prime and multi-channel fulfillment. Amazon calculates the average impact at approximately 17 cents per unit, though the actual amount varies based on item size and dimensions. The company said in a message to sellers that "elevated costs in fulfillment and logistics have increased the cost of operating across the industry" and noted that it had absorbed these increased costs prior to implementing the fee. Amazon spokesperson Ashley Vanicek characterized the surcharge as "significantly lower" than those applied by other major carriers. The fee applies to the approximately 2 million third-party sellers in both countries who rely on the FBA network. Amazon described the surcharge as temporary and stated it will remain in effect "until further notice."

The announcement places Amazon alongside UPS, FedEx, and USPS, all of which have implemented similar surcharges as the US-Iran conflict, now in its fifth week, pushes energy prices higher. USPS has separately proposed an 8% package surcharge set to begin April 26 and run through January 2027. For Amazon's third-party seller ecosystem, the new fee compresses already thin margins, particularly for high-volume, low-price goods where per-unit economics are most sensitive to incremental cost increases. The broader logistics industry is experiencing a synchronized repricing of services that had been priced under materially different energy assumptions. Investors in e-commerce and consumer goods companies should factor these surcharges into their models for Q2 and Q3 earnings, as sellers are likely to weigh price increases, inventory adjustments, or fulfillment channel diversification in response to the rising cost environment.

OpenAI Acquires Tech Talk Show TBPN in Media Push Ahead of Potential IPO

OpenAI announced the acquisition of TBPN, a streaming technology talk show regarded as essential viewing among Silicon Valley insiders, on approximately April 2-3, 2026. Financial terms were not disclosed, though the Financial Times reported the deal was valued in the low hundreds of millions of dollars. TBPN, which positions itself as a real-time competitor to Bloomberg and CNBC in technology news analysis and executive interviews, will become part of OpenAI's Strategy organization and report to Chief Global Affairs Officer Chris Lehane. The show will wind down its existing advertising business as part of the transition. OpenAI stated that TBPN will retain editorial independence over its programming, guest selections, and content decisions, while the organization itself will take on a broader role supporting OpenAI's communications and marketing operations outside the show. TBPN's hosts have previously stated that the show has never considered itself a journalistic outlet.

The acquisition has been widely interpreted as an effort by OpenAI to manage its public and investor narrative at a sensitive moment. The New York Times framed the deal as OpenAI buying the show with the aim of changing the broader narrative on artificial intelligence. The move aligns with a new communications strategy at the company and comes as OpenAI faces increasing regulatory scrutiny, intensifying competition, and growing speculation about a potential initial public offering. By controlling a media platform with genuine reach in the technology and investment communities, OpenAI positions itself to shape how its products, partnerships, and corporate decisions are covered and discussed. Critics are likely to question the independence of TBPN's editorial line despite OpenAI's assurances to the contrary. For investors monitoring the AI sector, the acquisition signals that leading AI companies are increasingly treating media access and narrative management as strategic assets rather than peripheral concerns.

Financial Trends: Exxon Mobil is targeting mid-single-digit annual production and cash flow growth with consensus modeling roughly flat revenues in the mid‑$330 billion range and EPS around $7 as commodity prices normalize.

Strategic Initiatives: Management is doubling down on low-cost Permian and Guyana barrels, integrating Pioneer assets, and scaling carbon capture and low-carbon solutions to support long-run earnings resilience.

Key Metrics: Investors will focus on upstream volumes, realized oil and gas prices, downstream/chemicals margins, and free cash flow available for dividends and buybacks versus capital spending.

Progress: Recent quarters have shown disciplined capex, strong operating cash flow above $13 billion per quarter, and continued execution on $9 billion-plus in annual shareholder distributions.

Focus Areas: Watch updated capital allocation plans post-Pioneer, carbon-reduction project milestones, and any change to long-term return-on-capital and earnings-growth targets under current price decks.

Risks Potential: Weaker commodity prices, refining margin compression, execution risk on megaprojects, and policy shifts around fossil fuels and carbon costs could all pressure returns.

Concerns: The street remains sensitive to downside revisions to medium-term EPS and free cash flow if oil prices retrace or project costs and energy-transition spending drift higher than guided.

Market Trends: Global oil demand growth is slowing but still positive while refining cycles and energy-transition policy noise keep sentiment volatile across integrated oil majors.

Financial Trends: Delta is guiding to roughly 4% annual revenue growth to about $66 billion and EPS around $6.8 in 2026, implying mid-teens earnings growth off 2025 levels despite fuel headwinds.

Strategic Initiatives: Management is leaning into a premium-first strategy, expanded partner network, and upcoming Boeing 787-10 fleet additions to lift unit revenue, efficiency, and long-haul profitability.

Key Metrics: Investors will key on total revenue growth, unit revenue (TRASM), non-fuel unit costs, fuel expense, and progress toward the $6.50–$7.50 EPS and $3–$4 billion free cash flow long-term targets.

Progress: Delta has already restored margins to the high-single digits with a 7.9% net margin and more than 20% return on equity in 2025 while reducing gross leverage to 2.4x and strengthening its balance sheet.

Focus Areas: Watch how management frames demand across corporate, international, and premium cabins, updated fuel and capacity assumptions, and any tweaks to full-year EPS or margin guidance.

Risks Potential: A sustained spike in jet fuel prices, macro slowdown hitting discretionary travel, operational disruptions, and wage inflation pose downside risk to earnings and free cash flow.

Concerns: Recent downward revisions to 2026 EPS estimates and sensitivity of guidance to volatile oil prices have kept some investors wary of near-term estimate cuts.

Market Trends: Industry-wide guidance raises on strong travel demand contrast with fuel-driven cost pressure, creating a tug-of-war between revenue momentum and margin sustainability across legacy carriers.

Financial Trends: Constellation is guiding fiscal 2026 comparable EPS to roughly $11.30–$11.60 with enterprise organic net sales expected to decline 4–6%, reflecting beer volume pressure and a structurally smaller wine-and-spirits footprint.

Strategic Initiatives: Management is prioritizing its core Mexican beer portfolio, brand-building for labels like Modelo and Corona, and cost-savings and portfolio rationalization across wine and spirits.

Key Metrics: Investors will focus on beer net sales and volume trends, pricing and mix, enterprise organic net sales, and comparable operating income trajectory versus the updated outlook.

Progress: The company has consistently beaten EPS expectations in recent quarters while delivering over $100 million in cost savings and executing on SKU and asset pruning in lower-return categories.

Focus Areas: Watch for updated FY26 guidance on beer volumes, margins, and capital allocation, along with commentary on consumer elasticity and competitive dynamics in U.S. beer.

Risks Potential: Macro-driven demand softness, beer volume declines, tariff and cost inflation, and continued weakness in wine and spirits could all weigh on growth and profitability.

Concerns: Management’s cut to enterprise and beer net sales and comparable operating income guidance has amplified worries about the durability of the growth algorithm beyond price-led gains.

Market Trends: Slowing U.S. beer category volumes, shifting consumer preferences, and a more promotional environment are challenging premium beer players even as strong brands can still take share.

From a young age, Evan was fascinated by the stock market. At just 11 years old, he received a Wall Street Journal subscription for his birthday, sparking a lifelong passion for investing. Evan spent his formative years studying the strategies and philosophies of legendary investors like Paul Tudor Jones, Stanley Druckenmiller, and George Soros, absorbing their wisdom and developing his own unique approach to the markets.

As Evan's knowledge grew, he began to incorporate the time-tested, technically-based strategies of trading legends like William O'Neil and Richard Wyckoff into his own investment framework. By borrowing elements from each and rigorously testing them in real-time, Evan created a powerful conglomerate strategy that encompasses fundamentals, technicals, and macroeconomics.

Today, Evan is a professional trader and was a top contender in the 2020 US Investing Championship. His extraordinary performance, with a 141.8% return, is a testament to his studious background, well-informed approach, and unwavering dedication to his craft.

At the core of Evan's strategy is identifying stocks that benefit from sector trends and rotation. By combining fundamental analysis with a focus on relative strength and advanced technical analysis techniques, Evan is able to identify the stocks that are most likely to move higher or lower over the intermediate term.

While he keeps a close eye on macroeconomic trends, his willingness to adapt to changing market conditions, as well as his developed ability to know when to and not to act in a fast-moving market, is what sets him apart. Evan has consistently demonstrated his ability to navigate even the most challenging investment environments. His impressive track record and unique perspective make him a valuable voice in the world of finance, and he is thrilled to have the opportunity to share his insights and expertise with subscribers of the Bull and Bear Brief.